What's New

Last Posted: Jan 22, 2021

• Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.
  Shimabukuro Tom et al. JAMA 2021 Jan
• Clinical prediction rule for SARS-CoV-2 infection from 116 U.S. emergency departments
  J Kline et al, MEDRXIV, January 22, 2021
• High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients
  C Liu et al, NPJ Genomic Medicine, January 21, 2021
• Real-World Clinical Performance of the Abbott Panbio with Nasopharyngeal, Throat and Saliva Swabs Among Symptomatic Individuals with COVID-19
  W Stokes et al, MEDRXIV, January 21, 2021
• Severity Prediction for COVID-19 Patients via Recurrent Neural Networks
  J Lee et al, MEDRXIV, January 21, 2021
• Testing in a Pandemic - Improving Access, Coordination, and Prioritization.
  Botti-Lodovico Yolanda et al. The New England journal of medicine 2021 Jan (3) 197-199
• Epidemic waves of COVID-19 in Scotland: a genomic perspective on the impact of the introduction and relaxation of lockdown on SARS-CoV-2
  SJ Lycett et al, MEDRXIV, January 20, 2021
• Factors associated with COVID-19 related hospitalisation, critical care admission and mortality using linked primary and secondary care data
  L Cummings et al, MEDRXIV, January 20, 2021
• Fast-spreading COVID variant can elude immune responses- Evidence that a variant of the coronavirus identified in South Africa might compromise immunity sparks concerns about vaccine effectiveness.
  E Callaway, Nature News, January 21, 2021
• Head-to-head comparison of direct-input RT-PCR and RT-LAMP against RTqPCR on extracted RNA for rapid SARS-CoV-2 diagnostics
  MJ Kellner et al, MEDRXIV, January 20, 2021